• Artículo
      Icon

      Ustekinumab in Crohn’s disease: real-world outcomes and predictors of response 

      Lorenzo González, Laura; Valdés Delgado, Teresa; Vázquez Morón, Juan María; Castro Laria, Luisa; Leo Carnerero, Eduardo; Maldonado Pérez, María Belén; Sánchez Capilla, Damián; Pallarés Manrique, Héctor; Sáez Díaz, Antonia; Argüelles Arias, Federico (Aran Ediciones S.A., 2022)
      Background: ustekinumab is a monoclonal antibody that inhibits interleukins IL-12 and IL-23, and is approved for the ...